Cargando…

Cholesterol efflux capacity is associated with lipoprotein size and vascular health in mild to moderate psoriasis

BACKGROUND AND OBJECTIVE: Psoriasis is a systemic inflammatory condition with poor cholesterol transport measured by cholesterol efflux capacity (CEC) that is associated with a heightened risk of cardiovascular disease (CVD). In psoriasis patients, we sought to characterize the lipoprotein profile b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berg, Alexander R., Petrole, Rylee F., Li, Haiou, Sorokin, Alexander V., Gonzalez-Cantero, Alvaro, Playford, Martin P., Mehta, Nehal N., Teague, Heather L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986595/ https://www.ncbi.nlm.nih.gov/pubmed/36891247 http://dx.doi.org/10.3389/fcvm.2023.1041457

Ejemplares similares

Myeloperoxidase and its negative relationship with cholesterol efflux capacity in patients with psoriasis: results from an observational cohort study
por: Florida, Elizabeth M., et al.
Publicado: (2023)

The Association Between Reduction in Inflammation and Changes in Lipoprotein Levels and HDL Cholesterol Efflux Capacity in Rheumatoid Arthritis
por: Liao, Katherine P., et al.
Publicado: (2015)

Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study
por: Gourgari, Evgenia, et al.
Publicado: (2018)

Estimated sdLDL-C for predicting high-risk coronary plaque features in psoriasis: a prospective observational study
por: Sorokin, Alexander V., et al.
Publicado: (2023)

Moderate‐ and High‐Intensity Exercise Improves Lipoprotein Profile and Cholesterol Efflux Capacity in Healthy Young Men
por: Stanton, Kelly M., et al.
Publicado: (2022)

Longitudinal association of epicardial and thoracic adipose tissues with coronary and cardiac characteristics in psoriasis
por: O'Hagan, Ross, et al.
Publicado: (2023)

High density lipoprotein cholesterol function improves after successful treatment of psoriasis: a step forward in the right direction
por: Mehta, Nehal N., et al.
Publicado: (2014)

Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Reveals a More Atherogenic Profile
por: Tom, Wynnis L., et al.
Publicado: (2016)

Impact of Endothelial Lipase on Cholesterol Efflux Capacity of Serum and High-density Lipoprotein
por: Schilcher, Irene, et al.
Publicado: (2017)

Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis
por: Hong, Christin G., et al.
Publicado: (2023)

PET/CT-Based Characterization of 18F-FDG Uptake in Various Tissues Reveals Novel Potential Contributions to Coronary Artery Disease in Psoriatic Arthritis
por: Schwartz, Daniella M., et al.
Publicado: (2022)

Cell-free, high-density lipoprotein–specific phospholipid efflux assay predicts incident cardiovascular disease
por: Sato, Masaki, et al.
Publicado: (2023)

Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies
por: Hokstad, Ingrid, et al.
Publicado: (2022)

Large-Scale Analysis of Determinants, Stability, and Heritability of High-Density Lipoprotein Cholesterol Efflux Capacity
por: Koekemoer, Andrea L., et al.
Publicado: (2017)

High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
por: Adorni, Maria Pia, et al.
Publicado: (2021)

High-Density Lipoprotein Cholesterol Efflux Capacity as a Novel Prognostic Surrogate for Coronary Artery Disease
por: Hisauchi, Itaru, et al.
Publicado: (2021)

Cholesterol efflux alterations in adolescent obesity: role of adipose-derived extracellular vesical microRNAs
por: Barberio, Matthew D., et al.
Publicado: (2019)

High-density lipoprotein cholesterol efflux capacity and incidence of coronary artery disease and cardiovascular mortality: a systematic review and meta-analysis
por: Cheng, Wenke, et al.
Publicado: (2022)

Prolonged bedrest reduces plasma high-density lipoprotein levels linked to markedly suppressed cholesterol efflux capacity
por: Trakaki, Athina, et al.
Publicado: (2020)

High-density lipoprotein cholesterol efflux capacity in patients with obstructive sleep apnea and its relation with disease severity
por: Fadaei, Reza, et al.
Publicado: (2022)

Abdominal subcutaneous adipose tissue negatively associates with subclinical coronary artery disease in men with psoriasis
por: Teklu, Meron, et al.
Publicado: (2021)

Variants at the APOE/C1/C2/C4 Locus Modulate Cholesterol Efflux Capacity Independently of High‐Density Lipoprotein Cholesterol
por: Low‐Kam, Cécile, et al.
Publicado: (2018)

Cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosis
por: Kocyigit, Duygu, et al.
Publicado: (2021)

High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
por: Qiu, Chengfeng, et al.
Publicado: (2017)

High-Density Lipoprotein Cholesterol Efflux Capacity as a Surrogate Marker for Major Cardiac Adverse Events in Japanese Patients
por: Komatsu, Tomohiro, et al.
Publicado: (2021)

Cholesterol efflux capacity of high‐density lipoprotein was not associated with cognitive decline and brain structures in older people with diabetes mellitus
por: Wu, Yuanyuan, et al.
Publicado: (2022)

Targeted cholesterol efflux
por: Fang, Longhou, et al.
Publicado: (2013)

Uremia alters HDL composition and cholesterol efflux capacity
por: Holzer, Michael, et al.
Publicado: (2012)

High-Density Lipoprotein-Mediated Cholesterol Efflux Capacity Is Improved by Treatment With Antiretroviral Therapy in Acute Human Immunodeficiency Virus Infection
por: Lo, Janet, et al.
Publicado: (2014)

Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres: Effects of HDL Particle Remodeling on Cholesterol Efflux
por: Navdaev, Alexei V., et al.
Publicado: (2020)

Systemic consequences of abnormal cholesterol handling: Interdependent pathways of inflammation and dyslipidemia
por: O’Hagan, Ross, et al.
Publicado: (2022)

Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein
por: Luthi, Andrea J., et al.
Publicado: (2015)

ABCA1‐Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease
por: Yassine, Hussein N., et al.
Publicado: (2016)

Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus—Brief Report
por: Apro, Johanna, et al.
Publicado: (2016)

Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome
por: Furuyama, Fumiaki, et al.
Publicado: (2018)

Lipid-Based Nutrient Supplementation Increases High-Density Lipoprotein (HDL) Cholesterol Efflux Capacity and Is Associated with Changes in the HDL Glycoproteome in Children
por: Hong, Brian V., et al.
Publicado: (2021)

Correlations between the NMR Lipoprotein Profile, APOE Genotype, and Cholesterol Efflux Capacity of Fasting Plasma from Cognitively Healthy Elderly Adults
por: de Rojas, Itziar, et al.
Publicado: (2023)

Development and validation of novel automatable assay for cholesterol efflux capacity
por: Mutsuda, Yume, et al.
Publicado: (2023)

Potential Immunological Links Between Psoriasis and Cardiovascular Disease
por: Sajja, Aparna P., et al.
Publicado: (2018)

Metabolomic Profiling of Cholesterol Efflux Capacity in a Multiethnic Population: Insights From MESA
por: Hunter, Wynn G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9n6i71i229f2klnqh0kt13vl30